AbbVie · 17 hours ago
2026 QTAS Bioanalytical Intern (Master's)
South San Francisco, CA
Internship
Onsite
Intern
$59K/yr - $100K/yr
Start in 2026 SummerAbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines that address serious health issues. The QTAS team is looking for a motivated intern to support bioanalytical development, focusing on ex-vivo stimulation processes and ligand binding assays using human blood samples.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Perform ex-vivo stimulation of human blood
Perform ligand binding assay e.g. MSD, Olink etc, on human plasma samples
Possible to perform human PBMC immunophenotyping by flow cytometry
Qualification
Required
Currently enrolled in university, pursuing a Master's degree in Biology, Biochemistry, Immunology, Pharmacology, or related fields
Must be enrolled in university for at least one semester following the internship
Experience handling human blood samples
Proficiency in data analysis and summary
Strong skills in MS Office applications are essential
Good communication skills, quick learner, motivated, and team player
Preferred
Expected graduation date between December 2026 – June 2027
Experience with bench work in immunoassays such as ELISA and MSD
Familiarity with FACS assay is a plus
Experience with Prism, and scripting in Python or R is preferred
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
Founded in 2013
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-01-18
2026-01-17
Company data provided by crunchbase